Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease-Reference-Cited by-同舟云学术

Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease

Published:2001-06 Issue:6 Volume:17 Page:511-516
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Manfredi Roberto,Chiodo Francesco

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference25 articles.

1. Antiretroviral drug resistance testing in adults with HIV infection;Hirsch;JAMA,1998

2. Long-term therapeutic strategies in HIV;Miles;J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.,1997

3. Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure;Deeks;AIDS,1998

4. Department of Health and Human Services and Henry J. Kaiser Family Foundation: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998; 47 (RR-05):43–82.

5. Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and use;Moyle;Drugs,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22

2. HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies;National Institute of Allergy and Infectious Diseases, NIH;2009

3. Enfuvirtide Antiviral Activity despite Rebound Viremia and Resistance Mutations: Fitness Tampering or a Case of Persistent Braking on Entering?;The Journal of Infectious Diseases;2007-02

4. Therapy of HIV infection;Dermatologic Therapy;2004-12

5. Antiretroviral Drugs to Treat Human Immunodeficiency Virus Infections;Antiviral Agents, Vaccines, and Immunotherapies;2004-10-20